Tandem Diabetes Care Inc (TNDM)
44.07
+0.14
(+0.32%)
USD |
NASDAQ |
May 14, 16:00
44.06
-0.01
(-0.02%)
After-Hours: 20:00
Tandem Diabetes Care Revenue (Quarterly): 191.67M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 191.67M |
December 31, 2023 | 196.80M |
September 30, 2023 | 185.62M |
June 30, 2023 | 195.92M |
March 31, 2023 | 169.38M |
December 31, 2022 | 220.50M |
September 30, 2022 | 204.55M |
June 30, 2022 | 200.26M |
March 31, 2022 | 175.91M |
December 31, 2021 | 210.00M |
September 30, 2021 | 179.63M |
June 30, 2021 | 172.14M |
March 31, 2021 | 141.04M |
December 31, 2020 | 168.06M |
September 30, 2020 | 123.60M |
June 30, 2020 | 109.24M |
March 31, 2020 | 97.93M |
December 31, 2019 | 108.40M |
September 30, 2019 | 94.66M |
June 30, 2019 | 93.26M |
March 31, 2019 | 66.00M |
December 31, 2018 | 76.20M |
September 30, 2018 | 46.26M |
June 30, 2018 | 34.13M |
Date | Value |
---|---|
March 31, 2018 | 27.28M |
December 31, 2017 | 40.30M |
September 30, 2017 | 27.00M |
June 30, 2017 | 21.33M |
March 31, 2017 | 18.98M |
December 31, 2016 | 28.91M |
September 30, 2016 | 12.29M |
June 30, 2016 | 22.98M |
March 31, 2016 | 20.06M |
December 31, 2015 | 29.12M |
September 30, 2015 | 15.72M |
June 30, 2015 | 15.71M |
March 31, 2015 | 12.31M |
December 31, 2014 | 17.89M |
September 30, 2014 | 13.51M |
June 30, 2014 | 10.26M |
March 31, 2014 | 8.065M |
December 31, 2013 | 10.24M |
September 30, 2013 | 7.776M |
June 30, 2013 | 5.528M |
March 31, 2013 | 5.458M |
December 31, 2012 | 2.257M |
September 30, 2012 | 0.2177M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
93.26M
Minimum
Jun 2019
220.50M
Maximum
Dec 2022
161.93M
Average
174.02M
Median
Revenue (Quarterly) Benchmarks
Insulet Corp | 441.70M |
Stryker Corp | 5.243B |
Abbott Laboratories | 9.964B |
Integer Holdings Corp | 414.80M |
Twist Bioscience Corp | 75.30M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -42.72M |
Total Expenses (Quarterly) | 233.35M |
EPS Diluted (Quarterly) | -0.65 |
Enterprise Value | 2.726B |
Gross Profit Margin (Quarterly) | 49.39% |
Profit Margin (Quarterly) | -22.29% |
Earnings Yield | -4.92% |
Normalized Earnings Yield | -4.898 |